Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2007

View Archived Issues

Positive preclinical profile of the CRF1 antagonist MTIP in animal models of alcoholism

Nycomed restructures following Altana Pharma acquisition

MerLion and Merck Banyu enter new drug discovery alliance

VASTox acquires DanioLabs and Dextra Laboratories

Pain Therapeutics in-licenses new technology for treatment of hemophilia

Results from phase I study of AEOL-10150

Dll4 as a novel target for antiangiogenic drugs

Affirmative preclinical profile set BEZ-235 for clinical evaluation

Nilvadipine show positive preliminary results in Alzheimer's

Quinvaxem vaccinations in Ethiopia

Amira raises funding to advance drug candidates through proof of concept

New WHO guidance on pneumococcal vaccines in developing countries

NovaDel Pharma outlines 2007 goals

Hana Biosciences provides pipeline update

New treatment options for metabolic disorders are disclosed in patent literature

Novel therapeutic strategies for the treatment of infection described in recent patents

Synosis Therapeutics changes name to Synosia Therapeutics

Eisai granted rights to Eril in Korea

Genta expects negative European opinion for Genasense in advanced melanoma

EAU's new guidelines recommend Sutent in first-line metastatic RCC

Revlimid recommended for approval in E.U. for multiple myeloma

Altargo recommended for E.U. approval

E.U. recommends approval of Herceptin for new breast cancer indication

Januvia approved in E.U. for type 2 diabetes

Roche files sNDA for XELOX in metastatic colorectal cancer

A-620223 a potent inhibitor of poly(ADP-ribose) polymerase

GlaxoSmithKline identifies GSK-983 as potential human papillomavirus treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...